Literature DB >> 26136801

A case of oncogenic osteomalacia due to occult nasal sinus tumor.

Sayantan Ray1, Partha Pratim Chakraborty1, Kaushik Biswas1, Sujoy Ghosh1, Satinath Mukhopadhyay1, Subhankar Chowdhury1.   

Abstract

This paper shows a case of oncogenic osteomalacia in a 35-year-old man who presented with a 2-year history of generalized pain and progressive weakness of lower limbs, eventually became bed bound. At admission he had severe hip pain resulting from atraumatic femoral neck fractures. Laboratory investigations revealed hypophosphatemia, hyperphosphaturia, normocalcemia, elevated alkaline phosphatase, and normal serum levels of parathormone and 25-hydroxyvitamin D. Serum FGF-23 was elevated. Imaging showed osteoporosis and insufficiency fractures of the femoral neck. Whole body functional imaging failed to reveal any areas of increased activity. However, on computed tomography (CT) and magnetic resonance (MR) imaging, a tumor was discovered at left nasal cavity. The patient was treated with phosphate supplements and vitamin D, but his hypophosphatemia persisted. The tumor was surgically removed. Histologically, the tumor was diagnosed as variant of a sinonasal hemangiopericytoma-like tumor. After surgery, his symptoms were relieved and biochemical parameters normalized.

Entities:  

Keywords:  fibroblast growth factor 23; hemangiopericytoma; hypophosphatemia; nasal tumor; oncogenic osteomalacia

Year:  2015        PMID: 26136801      PMCID: PMC4469232          DOI: 10.11138/ccmbm/2015.12.1.065

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  17 in total

Review 1.  Oncogenic osteomalacia.

Authors:  M Sundaram; E F McCarthy
Journal:  Skeletal Radiol       Date:  2000-03       Impact factor: 2.199

2.  Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.

Authors:  Carlos Fuentealba; Delia Pinto; Francisco Ballesteros; Daniel Pacheco; Oscar Boettiger; Néstor Soto; Wanda Fernandez; Fernando Gabler; Gilberto Gonzales; Antonio J Reginato
Journal:  J Clin Rheumatol       Date:  2003-12       Impact factor: 3.517

3.  Nasal hemangiopericytoma causing oncogenic osteomalacia.

Authors:  Sung Il Cho; Nam Yong Do; Seung Woo Yu; Ji Yun Choi
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-09-15       Impact factor: 3.372

4.  A paranasal tumor associated with tumor-induced osteomalacia.

Authors:  Go Inokuchi; Hitoshi Tanimoto; Haruhiko Ishida; Toshitsugu Sugimoto; Mika Yamauchi; Akimitsu Miyauchi; Ken-Ichi Nibu
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

5.  Tumor-induced osteomalacia: a single center experience.

Authors:  Varsha S Jagtap; Vijaya Sarathi; Anurag R Lila; Gaurav Malhotra; Shilpa S Sankhe; Tushar Bandgar; Padmavathy Menon; Nalini S Shah
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

Review 6.  A haemangiopericytoma of the ethmoid sinus causing oncogenic osteomalacia: a case report and review of the literature.

Authors:  T J Beech; A Rokade; N Gittoes; A P Johnson
Journal:  Int J Oral Maxillofac Surg       Date:  2007-05-10       Impact factor: 2.789

Review 7.  Oncogenic osteomalacia: case report and review of head and neck associated tumours.

Authors:  X Gonzalez-Compta; M Mañós-Pujol; M Foglia-Fernandez; E Peral; E Condom; T Claveguera; M Dicenta-Sousa
Journal:  J Laryngol Otol       Date:  1998-04       Impact factor: 1.469

8.  Occult nasal sinus tumours causing oncogenic osteomalacia.

Authors:  Helen Kenealy; Ian Holdaway; Andrew Grey
Journal:  Eur J Intern Med       Date:  2008-03-10       Impact factor: 4.487

9.  Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy.

Authors:  Stephen F Hodgson; Bart L Clarke; Peter J Tebben; Brian P Mullan; William P Cooney; Thomas C Shives
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

10.  Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.

Authors:  G E Wilkins; S Granleese; R G Hegele; J Holden; D W Anderson; G P Bondy
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

View more
  7 in total

1.  Oncogenic hypophosphatemic osteomalacia: From the first signal of disease to the first signal of healthy.

Authors:  Arthur Paredes Gatti; Luiza Tonello; João Alfredo Diedrich Neto; Uirá Fernandes Teixeira; Marcos Bertozzi Goldoni; Paulo Roberto Ott Fontes; José Artur Sampaio; Luiz Maraninchi Pereira Lima; Fábio Luiz Waechter
Journal:  Int J Surg Case Rep       Date:  2016-11-27

2.  Perioperative management of patients with severe hypophosphataemia secondary to oncogenic osteomalacia: Our experience and review of literature.

Authors:  Alka Verma; Saipriya Tewari; Ashish Kannaujia
Journal:  Indian J Anaesth       Date:  2017-07

3.  Anterior Skull Base Glomangioma-Induced Osteomalacia.

Authors:  Malia S Gresham; Steven Shen; Yi J Zhang; Kelly Gallagher
Journal:  J Neurol Surg Rep       Date:  2017-01

4.  Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Weibo Xia; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

5.  A case of oncogenic osteomalacia owing to inguinal tumor.

Authors:  Luiza Tonello; Arthur Paredes Gatti; João Diedrich Neto; Uirá Fernandes Teixeira; Marcos Bertozzi Goldoni; Paulo Roberto Ott Fontes; José Artur Sampaio; Luiz Maraninchi Pereira Lima; Fábio Luiz Waechter
Journal:  Oxf Med Case Reports       Date:  2017-10-26

6.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

7.  Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.